Pharyngosept, tablets 10 mg 20 pcs

It has a bacteriostatic effect.

It has a local antimicrobial action.

It is active against a wide range of Gram-positive and Gram-negative microorganisms (Streptococcus haemolyticus, Streptococcus viridans, Pneumococcus).

Pharmacokinetics

The optimal therapeutic concentration in saliva is reached on the 3rd-4th day of taking the drug at the dose of 0,03-0,05 g/day.

Indications

Symptomatic treatment of infectious and inflammatory diseases of the oral cavity and pharynx.

Pharmacological effect

Has a bacteriostatic effect.

Has a local antimicrobial effect.

Active against a wide range of gram-positive and gram-negative microorganisms (Streptococcus haemolyticus, Streptococcus viridans, Pneumococcus).

Pharmacokinetics

The optimal therapeutic concentration in saliva is achieved on the 3-4th day of taking the drug at a dose of 0.03-0.05 g/day.

Special instructions

Increasing the dose does not have a greater clinical effect.

After taking ambazone, it is recommended to refrain from eating and drinking for 3 hours.

Active ingredient

Ambazon

Composition

Active ingredients:

ambazone monohydrate – 10 mg.

Contraindications

Hypersensitivity to ambazon.

Side Effects

Allergic reactions, skin rash.

Overdose

Not identified.

Storage conditions

At a temperature not exceeding 25 °C

Shelf life

4 years

Manufacturer

S.K. Therapy S.A., Romania